Posts by: Alice Melão

Researchers at the University of Texas at Austin developed an automated handheld device that accurately identifies cancerous tissue in as little as 10 seconds. The device, called MasSpec Pen, is ... Read more

June 8, 2017

Response to Neratinib and Xeloda Combo Seen in Breast Cancer Patients with Brain Metastasis

News

Combining Puma Biotechnology’s candidate therapy PB272, also known as neratinib, with the chemotherapy drug Xeloda (capecitabine) appears to have therapeutic potential for patients with advanced HER2-positive breast cancer and brain metastasis, who were not previously treated ... Read more

June 5, 2017June 7, 2017

Kisqali, Femara Combo Shows Promise in HR+/HER2- Advanced Breast Cancer Patients

News

The latest results from the Phase 3 MONALEESA-2 study showed that adding Novartis’ Kisqali (ribociclib) to ‎Femara (letrozole) for the treatment of breast cancer in certain postmenopausal women improves the ... Read more

June 1, 2017June 1, 2017

Keytruda Shows Meaningful Clinical Benefit When Combined with Standard Therapy for Aggressive Breast Cancer

News

Two independent studies have added new evidence to the benefits of combined therapies with Merck‘s PD-1 inhibitor Keytruda (pembrolizumab) for the treatment of aggressive triple-negative breast cancer (TNBC). Adding Keytruda to standard ... Read more

May 30, 2017

PMD-026 Reduces Triple Negative Breast Cancer Growth, Mice Study Shows

News

PMD-026 reduced tumor growth in mice with triple negative breast cancer (TNBC), according to its developer, Phoenix Molecular Designs. The therapy, which targets the RSK family of enzymes associated with ... Read more

April 3, 2017April 3, 2017

Two Proteins Predict Poorer Outcome in Male Breast Cancer, Study Reports

News

The proteins eIF4E and eIF5 are involved in male breast cancer (MBC), and are biomarkers of a poorer disease prognosis, according to researchers at the University of Leeds in England. ... Read more

March 15, 2017March 15, 2017

Diabetes Medication Used in Asia Seen to Target Aggressive Basal-like Breast Cancer

News

An enzyme known as AKR1B1 is highly expressed in basal-like breast cancer (BLBC) cells and appears to be an important mediator of cancer aggressiveness and metastatic ability, researchers in China reported. But ... Read more

March 7, 2017

Identifying Active Pathways in Triple Negative Breast Cancers Could Lead to More Effective Therapies

News

Determining gene expression patterns in triple negative breast cancer (TNBC) patients could identify the most effective treatment options for each patient, leading to more targeted, personalized care, according to ... Read more

February 8, 2017February 8, 2017

Investigational Drug Could Help Prevent Bone Degradation in Breast Cancer Patients

News

A new oral drug in a first-in-human clinical trial has shown promise in inhibiting the bone degradation caused by breast cancer cells, say researchers from the University of Utah’s ... Read more

January 6, 2017

Breast Cancer Patients Report ‘Chemo Brain’ Up to 6 Months After Treatment, Study Says

News

Breast cancer patients who have undergone chemotherapy can experience cognitive difficulties for up to six months after treatment, according to a new study. Impaired memory, trouble completing tasks, and ... Read more